Haemonetics Corporation (HAE) — Capital Reinvestment Ratio
Latest as of March 2026:
0.25x
Haemonetics Corporation (HAE) has a Capital Reinvestment Ratio of 0.25x as of March 2026, meaning it reinvests 0% of its operating cash flow ($70.94 Million) in capital expenditures ($17.66 Million). See Haemonetics Corporation free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.25x
Capex / Operating Cash Flow
Operating Cash Flow
$70.94 Million
USD
Capital Expenditures
$17.66 Million
USD
Data as of
Mar 2026
Most recent filing
Haemonetics Corporation Capital Reinvestment Ratio (1992–2026)
This chart tracks Haemonetics Corporation's Capital Reinvestment Ratio across 35 annual periods.
Annual Capital Reinvestment Ratio for Haemonetics Corporation (1992–2026)
Year-by-year Capital Reinvestment Ratio for Haemonetics Corporation from 1992 to 2026. For live market cap and broader valuation context, see market cap of Haemonetics Corporation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2026 | 0.11x | $293.22 Million | $32.78 Million | ▼ -48.3% |
| 2025 | 0.22x | $181.72 Million | $39.28 Million | ▼ -40.7% |
| 2024 | 0.36x | $181.75 Million | $66.30 Million | ▼ -9.6% |
| 2023 | 0.40x | $273.06 Million | $110.19 Million | ▼ -28.0% |
| 2022 | 0.56x | $172.26 Million | $96.51 Million | ▲ +64.6% |
| 2021 | 0.34x | $108.81 Million | $37.04 Million | ▲ +10.5% |
| 2020 | 0.31x | $158.22 Million | $48.76 Million | ▼ -58.7% |
| 2019 | 0.75x | $159.28 Million | $118.96 Million | ▲ +120.0% |
| 2018 | 0.34x | $220.35 Million | $74.80 Million | ▼ -28.8% |
| 2017 | 0.48x | $159.74 Million | $76.14 Million | ▼ -43.3% |
| 2016 | 0.84x | $121.86 Million | $102.41 Million | ▼ -12.6% |
| 2015 | 0.96x | $127.18 Million | $122.22 Million | ▲ +82.1% |
| 2014 | 0.53x | $139.52 Million | $73.65 Million | ▼ -27.8% |
| 2013 | 0.73x | $85.07 Million | $62.19 Million | ▲ +58.5% |
| 2012 | 0.46x | $115.32 Million | $53.20 Million | ▲ +22.0% |
| 2011 | 0.38x | $123.45 Million | $46.67 Million | ▼ -12.3% |
| 2010 | 0.43x | $130.67 Million | $56.30 Million | ▼ -11.1% |
| 2009 | 0.48x | $116.36 Million | $56.38 Million | ▼ -34.9% |
| 2008 | 0.74x | $77.67 Million | $57.79 Million | ▲ +50.0% |
| 2007 | 0.50x | $83.56 Million | $41.46 Million | ▲ +15.5% |
| 2006 | 0.43x | $85.62 Million | $36.77 Million | ▲ +74.5% |
| 2005 | 0.25x | $71.21 Million | $17.53 Million | ▲ +32.5% |
| 2004 | 0.19x | $74.61 Million | $13.86 Million | ▼ -40.1% |
| 2003 | 0.31x | $43.67 Million | $13.54 Million | ▼ -53.7% |
| 2002 | 0.67x | $32.24 Million | $21.60 Million | ▲ +33.9% |
| 2001 | 0.50x | $61.01 Million | $30.54 Million | ▲ +14.8% |
| 2000 | 0.44x | $53.47 Million | $23.32 Million | ▼ -34.7% |
| 1999 | 0.67x | $33.70 Million | $22.50 Million | ▼ -33.2% |
| 1998 | 1.00x | $20.40 Million | $20.40 Million | ▼ -16.6% |
| 1997 | 1.20x | $26.70 Million | $32.00 Million | ▲ +233.4% |
| 1996 | 0.36x | $54.80 Million | $19.70 Million | ▼ -77.5% |
| 1995 | 1.60x | $15.60 Million | $24.90 Million | ▲ +88.2% |
| 1994 | 0.85x | $27.00 Million | $22.90 Million | ▲ +73.0% |
| 1993 | 0.49x | $35.90 Million | $17.60 Million | ▼ -19.2% |
| 1992 | 0.61x | $18.80 Million | $11.40 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow